Rapidly testing hundreds of thousands of DNA sequences, scientists identified specific genetic variations contributing to blood pressure, cholesterol, and blood sugar.

Apheris's ADMET Network will combine proprietary datasets in a privacy-preserving environment to accelerate AI drug discovery models.

Scientists have identified how specific genetic changes function in cells to influence disease risk and other human health traits. By probing regions of DNA previously linked to disease, the work has ...

The Stanford Emerging Review 2026 describes biotechnology and synthetic biology as emerging general-purpose technologies.

Vector-borne diseases (VBDs) represent a critical challenge in infectious disease control due to their complex transmission dynamics, diverse vector ...

RNA structural biology has rapidly evolved from interpreting RNA as a passive genetic messenger to positioning it as a key programmable component for ...

March issue of National Geographic explores how engineered silkworms are spinning one of nature’s most powerful materials at ...

Credit: Anna Tutova (Founder AI Crypto Minds) with Ben Lamm (co-Founder & CEO Colossal Biosciences) at World Governments Summit in Dubai.

US trade deal, the Modi government has effectively sold off the interests of Indian farmers, writes Rashme Sehgal ...

ADRIAN WOOLFSON, scientist and founder of Genyro, has authored a brave new book, 'On the Future of Species'. Here, Woolfson examines with SUCHETA DASGUPTA the future of humanity in a world of AI ...

The 2026 Priestley Medalist and Nobel laureate struggled with finding her way through school before achieving the greatest feats in science ...

DENVER, Feb. 18, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...